However, interestingly, the ratio of ICOS+ CD4+ T-cells to FoxP3+ CD4+ T-cells significantly increased from 7% pre-vaccination to 23% post-vaccination, which is also accompanied by a three-fold increase in the IFN-γ response in CD4+ T-cells following vaccination to breast cancer patients. Here, IFNG is linked to breast carcinoma.